NCT01618825View on ClinicalTrials.gov

Bioequivalence Study of Lamotrigine Tablets 25 mg (2 x 25 mg Tablets) Under Fed Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Fed
Interventions
DRUG

Lamotrigine Tablets 25 mg

2 x 25 mg tablet once a day

DRUG

Lamotrigine

2 x 25 mg tablet once a day

Trial Locations (1)

Unknown

Cliantha Research Limited, Ahmedabad

Sponsors
All Listed Sponsors
lead

IPCA Laboratories Ltd.

INDUSTRY